Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Timmerman

Showing results (171-180 of 222) with videos related to

Pageof 23
Sort By:
BMJ (Clinical Research Ed.)|March 6, 2015
Dharmasena case illustrates what is wrong with complaints proceduresTom Bourne, Phillip Bennett, Shabnam Bobdiwala, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|November 24, 2020
A Prospective International Lung Ultrasound Analysis Study in Tertiary Maternity Wards During the Severe Acute Respiratory Syndrome Coronavirus 2 PandemicFrancesca Moro, Danilo Buonsenso, Johannes van der Merwe, et al.
BMJ (Clinical Research Ed.)|January 24, 2013
NICE guidance on ectopic pregnancy and miscarriage restricts access and choice and may be clinically unsafeTom Bourne, Kurt Barnhart, Carol B Benson, et al.
BMJ (Clinical Research Ed.)|December 16, 2010
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA groupDirk Timmerman, Lieveke Ameye, Daniela Fischerova, et al.
The Lancet. Digital Health|December 14, 2025
Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidanceBen Van Calster, Gary S Collins, Andrew J Vickers, et al.
Gynecologic Oncology|April 13, 2013
A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian massesAhmad Sayasneh, Jeroen Kaijser, Jessica Preisler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 13, 2011
A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational studyBen Van Calster, Lil Valentin, Caroline Van Holsbeke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2025
Circulating tumor DNA in the diagnosis of ovarian cancer: a systematic reviewCristina Taliento, Pantaleo Greco, Giulia Bruni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2017
Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve AnalysisLaure Wynants, Dirk Timmerman, Jan Y Verbakel, et al.
American Journal of Obstetrics and Gynecology|July 13, 2025
External validation of ultrasound-based models for differentiating between benign and malignant adnexal masses: a nationwide prospective multicenter study (IOTA phase 6)Francesca Moro, Marina Momi, Ashleigh Ledger, et al.
Pageof 23

Showing results (171-180 of 222) with videos related to

Sort By:
Pageof 23
BMJ (Clinical Research Ed.)|March 6, 2015
Dharmasena case illustrates what is wrong with complaints proceduresTom Bourne, Phillip Bennett, Shabnam Bobdiwala, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|November 24, 2020
A Prospective International Lung Ultrasound Analysis Study in Tertiary Maternity Wards During the Severe Acute Respiratory Syndrome Coronavirus 2 PandemicFrancesca Moro, Danilo Buonsenso, Johannes van der Merwe, et al.
BMJ (Clinical Research Ed.)|January 24, 2013
NICE guidance on ectopic pregnancy and miscarriage restricts access and choice and may be clinically unsafeTom Bourne, Kurt Barnhart, Carol B Benson, et al.
BMJ (Clinical Research Ed.)|December 16, 2010
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA groupDirk Timmerman, Lieveke Ameye, Daniela Fischerova, et al.
The Lancet. Digital Health|December 14, 2025
Evaluation of performance measures in predictive artificial intelligence models to support medical decisions: overview and guidanceBen Van Calster, Gary S Collins, Andrew J Vickers, et al.
Gynecologic Oncology|April 13, 2013
A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian massesAhmad Sayasneh, Jeroen Kaijser, Jessica Preisler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 13, 2011
A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational studyBen Van Calster, Lil Valentin, Caroline Van Holsbeke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 24, 2025
Circulating tumor DNA in the diagnosis of ovarian cancer: a systematic reviewCristina Taliento, Pantaleo Greco, Giulia Bruni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2017
Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve AnalysisLaure Wynants, Dirk Timmerman, Jan Y Verbakel, et al.
American Journal of Obstetrics and Gynecology|July 13, 2025
External validation of ultrasound-based models for differentiating between benign and malignant adnexal masses: a nationwide prospective multicenter study (IOTA phase 6)Francesca Moro, Marina Momi, Ashleigh Ledger, et al.
Pageof 23